Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B

(2010) Ting-Tsung Chang et al.   HEPATOLOGY

Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels

(2010) Vincent Rijckborst et al.   HEPATOLOGY

98 EXTENDED (2 YEARS) TREATMENT WITH PEGINTERFERON ALFA-2A [40KD] IMPROVES SUSTAINED RESPONSE RATES IN GENOTYPE D PATIENTS WITH HBEAG NEGATIVE CHRONIC HEPATITIS B

(2010) P. Lampertico et al.   JOURNAL OF HEPATOLOGY

Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia

(2010) Tin Nguyen et al.   JOURNAL OF HEPATOLOGY

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective

(2010) Jerzy Jaroszewicz et al.   JOURNAL OF HEPATOLOGY

Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-α2a

(2009) Rami Moucari et al.   ANTIVIRAL THERAPY

Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a

(2009) Patrick Marcellin et al.   GASTROENTEROLOGY

Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus

(2009) Josephine Simonetti et al.   HEPATOLOGY

Hepatitis B virus infection

(2009) Yun-Fan Liaw et al.   LANCET

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients

(2008) Rami Moucari et al.   HEPATOLOGY

Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B

(2008) Maurizia Rossana Brunetto et al.   HEPATOLOGY

EASL Clinical Practice Guidelines: Management of chronic hepatitis B

(2008)   JOURNAL OF HEPATOLOGY

Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B

(2008) Patrick Marcellin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors

(2007) Giovanna Fattovich et al.   JOURNAL OF HEPATOLOGY